243 related articles for article (PubMed ID: 9411822)
1. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
[TBL] [Abstract][Full Text] [Related]
3. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
Bukowska H
Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
[TBL] [Abstract][Full Text] [Related]
4. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
5. [Importance of lipoprotein(a) in patients with ischemic heart disease].
Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
[TBL] [Abstract][Full Text] [Related]
6. The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease.
Bilgen D; Sönmez H; Ekmekçi H; Ulutin T; Oztürk Z; Kökoğlu E; Bayram C; Soner A; Domaniç N
Clin Biochem; 2005 Jan; 38(1):92-6. PubMed ID: 15607324
[TBL] [Abstract][Full Text] [Related]
7. [National study of lipids in coronary patients].
Roqué F; Amuchástegui LM; Mon G; Giannone C
Medicina (B Aires); 1992; 52(1):10-6. PubMed ID: 1343578
[TBL] [Abstract][Full Text] [Related]
8. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
[TBL] [Abstract][Full Text] [Related]
9. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease.
Krecki R; Drozdz J; Szcześniak P; Orszulak-Michalak D; Krzemińska-Pakuła M
Kardiol Pol; 2008 Nov; 66(11):1173-80; discussion 1181-2. PubMed ID: 19105094
[TBL] [Abstract][Full Text] [Related]
10. Serum Lp(a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities.
Dionyssiou-Asteriou A; Papastamatiou M; Vatalas I; Bastounis E
Eur J Vasc Endovasc Surg; 2000 Jul; 20(1):57-60. PubMed ID: 10906299
[TBL] [Abstract][Full Text] [Related]
11. Plasma Lp(a) levels correlate with number, severity, and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis.
Budde T; Fechtrup C; Bösenberg E; Vielhauer C; Enbergs A; Schulte H; Assmann G; Breithardt G
Arterioscler Thromb; 1994 Nov; 14(11):1730-6. PubMed ID: 7947596
[TBL] [Abstract][Full Text] [Related]
12. [Homocysteine, lipoprotein (a): risk factors for coronary heart disease].
Laraqui A; Bennouar N; Meggouh F; Allami A; El Kadiri N; Benkouka F; Azeddoug H; El Haitem N; Benomar A; Fellat S; Benomar M
Ann Biol Clin (Paris); 2002; 60(5):549-57. PubMed ID: 12368140
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
Gaeta G; Cuomo S; Capozzi G; Foglia MC; Barra S; Madrid A; Stornaiuolo V; Trevisan M
Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
[TBL] [Abstract][Full Text] [Related]
15. [Lipoprotein (a) and ischemic heart diseases in patients with type 2 diabetes].
Ben Hamda K; Masmoudi AS; Mandhouj O; Hammami S; Attia N; Smaoui M; Zidi MA; Nabli N; Chaaba R; Mahjoub S; Ben Farhat M; Hammami M
Arch Inst Pasteur Tunis; 2002; 79(1-4):27-33. PubMed ID: 15072242
[TBL] [Abstract][Full Text] [Related]
16. [Association between lipoprotein(a) and coronary disease].
Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
[TBL] [Abstract][Full Text] [Related]
17. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
18. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat.
Burman A; Jain K; Gulati R; Chopra V; Agarwal DP; Vasisht S
J Assoc Physicians India; 2004 Feb; 52():99-102. PubMed ID: 15656041
[TBL] [Abstract][Full Text] [Related]
20. [An experience of lipoprotein (a) dosage in a Moroccan population of 184 subjects].
Fellat S; Lahfidi K; Sraïri JE; el Haïtem N; Mesbahi R; Ghanam R; Benomar M
Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1371-6. PubMed ID: 9539837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
